KODIAK SCIENCES INC. Increase (Decrease) in Prepaid Expense and Other Assets
KODIAK SCIENCES INC. (KOD) reported Increase (Decrease) in Prepaid Expense and Other Assets of $635.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- KODIAK SCIENCES INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$340.00K.
- KODIAK SCIENCES INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $975.00K.
- KODIAK SCIENCES INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $1.06M.
- KODIAK SCIENCES INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$64.00K.
- KODIAK SCIENCES INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $891.00K, a 1385.00% increase from fiscal 2024.
- KODIAK SCIENCES INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $60.00K.
- KODIAK SCIENCES INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$8.45M, a 407.98% decline from fiscal 2022.
- KODIAK SCIENCES INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $2.74M, a 916.30% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$340.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $635.00K 10-Q · filed 2026-08-13 | $1.70M derived: sum of 3 quarters · filed 2026-08-13 | $1.63M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $975.00K 10-Q · filed 2026-05-07 | $2.04M derived: sum of 2 quarters · filed 2026-05-07 | $1.97M derived: sum of 3 quarters · filed 2026-05-07 | $1.89M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $999.00K derived: sum of 2 quarters · filed 2026-03-31 | $919.00K derived: sum of 3 quarters · filed 2026-08-13 | $891.00K 10-K · filed 2026-03-31 | |
| 2025-09-30 | -$64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$144.00K derived: sum of 2 quarters · filed 2026-08-13 | -$172.00K 10-Q · filed 2025-11-13 | -$939.00K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | -$80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$108.00K 10-Q · filed 2026-08-13 | -$875.00K derived: sum of 3 quarters · filed 2026-08-13 | -$1.65M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | -$28.00K 10-Q · filed 2026-05-07 | -$795.00K derived: sum of 2 quarters · filed 2026-05-07 | -$1.57M derived: sum of 3 quarters · filed 2026-05-07 | -$1.76M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | -$767.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$1.54M derived: sum of 2 quarters · filed 2026-03-31 | -$1.73M derived: sum of 3 quarters · filed 2026-03-31 | $60.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$774.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$964.00K derived: sum of 2 quarters · filed 2025-11-13 | $827.00K 10-Q · filed 2025-11-13 | -$630.00K derived: sum of 4 quarters · filed 2026-03-31 | |
| 2024-06-30 | -$190.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $1.60M 10-Q · filed 2025-08-13 | $144.00K derived: sum of 3 quarters · filed 2026-03-31 | -$2.89M derived: sum of 4 quarters · filed 2026-03-31 | |
| 2024-03-31 | $1.79M 10-Q · filed 2025-05-14 | $334.00K derived: sum of 2 quarters · filed 2026-03-31 | -$2.70M derived: sum of 3 quarters · filed 2026-03-31 | -$4.33M derived: sum of 4 quarters · filed 2026-03-31 | |
| 2023-12-31 | -$1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$4.49M derived: sum of 2 quarters · filed 2026-03-31 | -$6.13M derived: sum of 3 quarters · filed 2026-03-31 | -$8.45M 10-K · filed 2026-03-31 | |
| 2023-09-30 | -$3.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$4.67M derived: sum of 2 quarters · filed 2024-11-14 | -$6.99M 10-Q · filed 2024-11-14 | -$7.19M derived: sum of 4 quarters · filed 2025-03-27 | |
| 2023-06-30 | -$1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$3.96M 10-Q · filed 2024-08-14 | -$4.16M derived: sum of 3 quarters · filed 2025-03-27 | -$3.38M derived: sum of 4 quarters · filed 2025-03-27 | |
| 2023-03-31 | -$2.33M 10-Q · filed 2024-05-15 | -$2.52M derived: sum of 2 quarters · filed 2025-03-27 | -$1.75M derived: sum of 3 quarters · filed 2025-03-27 | -$6.74M derived: sum of 4 quarters · filed 2025-03-27 | |
| 2022-12-31 | -$195.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $579.00K derived: sum of 2 quarters · filed 2025-03-27 | -$4.42M derived: sum of 3 quarters · filed 2025-03-27 | $2.74M 10-K · filed 2025-03-27 | |
| 2022-09-30 | $774.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$4.22M derived: sum of 2 quarters · filed 2023-11-14 | $2.94M 10-Q · filed 2023-11-14 | -$19.00K derived: sum of 4 quarters · filed 2024-03-28 | |
| 2022-06-30 | -$4.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.17M 10-Q · filed 2023-08-14 | -$793.00K derived: sum of 3 quarters · filed 2024-03-28 | $2.00M derived: sum of 4 quarters · filed 2024-03-28 | |
| 2022-03-31 | $7.16M 10-Q · filed 2023-05-15 | $4.20M derived: sum of 2 quarters · filed 2024-03-28 | $7.00M derived: sum of 3 quarters · filed 2024-03-28 | $7.55M derived: sum of 4 quarters · filed 2024-03-28 | |
| 2021-12-31 | -$2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$161.00K derived: sum of 2 quarters · filed 2024-03-28 | $389.00K derived: sum of 3 quarters · filed 2024-03-28 | $270.00K 10-K · filed 2024-03-28 | |
| 2021-09-30 | $2.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.35M derived: sum of 2 quarters · filed 2022-11-09 | $3.23M 10-Q · filed 2022-11-09 | $4.96M derived: sum of 4 quarters · filed 2023-03-28 | |
| 2021-06-30 | $550.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $431.00K 10-Q · filed 2022-08-09 | -$431.00K 10-Q · filed 2021-08-09 | $2.17M derived: sum of 3 quarters · filed 2023-03-28 | -$284.00K derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-03-31 | -$119.00K 10-Q · filed 2022-05-10 | $1.62M derived: sum of 2 quarters · filed 2023-03-28 | -$834.00K derived: sum of 3 quarters · filed 2023-03-28 | -$34.00K derived: sum of 4 quarters · filed 2023-03-28 | |
| 2020-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$715.00K derived: sum of 2 quarters · filed 2023-03-28 | $85.00K derived: sum of 3 quarters · filed 2023-03-28 | $218.00K 10-K · filed 2023-03-28 | |
| 2020-09-30 | -$2.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$1.65M derived: sum of 2 quarters · filed 2021-11-09 | -$1.52M 10-Q · filed 2021-11-09 | $432.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $933.00K 10-Q · filed 2021-08-09 | -$933.00K 10-Q · filed 2020-08-10 | $2.88M derived: sum of 3 quarters · filed 2022-03-01 | $949.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $133.00K 10-Q · filed 2021-05-10 | $2.08M derived: sum of 2 quarters · filed 2022-03-01 | $149.00K derived: sum of 3 quarters · filed 2022-03-01 | $284.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $16.00K derived: sum of 2 quarters · filed 2022-03-01 | $151.00K derived: sum of 3 quarters · filed 2022-03-01 | $168.00K 10-K · filed 2022-03-01 | |
| 2019-09-30 | -$1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$1.80M derived: sum of 2 quarters · filed 2020-11-09 | -$1.78M 10-Q · filed 2020-11-09 | -$290.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | $135.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $152.00K 10-Q · filed 2020-08-10 | $1.64M derived: sum of 3 quarters · filed 2021-03-01 | $1.88M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | $17.00K 10-Q · filed 2020-05-11 | $1.51M derived: sum of 2 quarters · filed 2021-03-01 | $1.75M derived: sum of 3 quarters · filed 2021-03-01 | $1.92M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.73M derived: sum of 2 quarters · filed 2021-03-01 | $1.91M derived: sum of 3 quarters · filed 2021-03-01 | $2.00M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $238.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $413.00K derived: sum of 2 quarters · filed 2019-11-12 | $503.00K 10-Q · filed 2019-11-12 | $558.00K derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-06-30 | $175.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $265.00K 10-Q · filed 2019-08-14 | $320.00K derived: sum of 3 quarters · filed 2020-03-16 | ||
| 2018-03-31 | $90.00K 10-Q · filed 2019-05-15 | $145.00K derived: sum of 2 quarters · filed 2020-03-16 | |||
| 2017-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$368.00K 10-K · filed 2020-03-16 | |||
| 2017-09-30 | -$423.00K 10-Q · filed 2018-11-16 | ||||
| 2016-12-31 | -$270.00K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |